1. Introduction: Phylogeny and Modern Taxonomy of Filoviridae
The family Filoviridae (order Mononegavirales) comprises enveloped, negative-sense, single-stranded RNA viruses causing severe hemorrhagic fevers in humans and primates, notably the 2014–2016 West African Ebola epidemic and the 2026 Bundibugyo virus crisis in the Democratic Republic of the Congo (DRC) and Uganda[1][2][4][6]. Under 2025–2026 Master Species List updates (MSL40/MSL41) ratified by the International Committee on Taxonomy of Viruses (ICTV), filovirus taxonomy spans mammalian, piscine, and reptilian hosts[4][8][9][11]. While Orthoebolavirus and Orthomarburgvirus drive major public health emergencies, bat-borne Cuevavirus (Lloviu virus) and Dianlovirus reflect wide Eurasian chiropteran diversity without causing severe disease in interferon-knockout mice[11][12][14].
| Genus | Representative Species | Virus Name (Abbreviation) | Primary Known Host/Reservoir | Human Pathogenicity |
|---|---|---|---|---|
| Orthoebolavirus | O. zairense | Ebola virus (EBOV) | Bats (suspected), Primates | Extremely High |
| Orthoebolavirus | O. sudanense | Sudan virus (SUDV) | Unknown | High |
| Orthoebolavirus | O. bundibugyoense | Bundibugyo virus (BDBV) | Unknown | High |
| Orthoebolavirus | O. restonense | Reston virus (RESTV) | Macaques, Domestic Pigs | Apathogenic |
| Orthoebolavirus | O. bombaliense | Bombali virus (BOMV) | Free-tailed bats | Likely Low |
| Orthoebolavirus | O. taiense | Taï Forest virus (TAFV) | Unknown | High |
| Orthomarburgvirus | O. marburgense | Marburg / Ravn virus (MARV/RAVV) | Egyptian fruit bats | Extremely High |
| Cuevavirus | C. lloviuense | Lloviu virus (LLOV) | Schreiber's bats | Unobserved |
| Dianlovirus | D. menglaense | Mengla virus (MLAV) | Bats | Unknown |
| Striavirus / Thamnovirus | S. antennarii / T. percae | Xilang / Fiwi virus | Fish | Non-mammalian |
| Tapjovirus | T. bothropis | Tapajos virus (TAPV) | Reptiles | Non-mammalian |
2. Virion Architecture, Helical Nucleocapsids, and Transcriptional Gradients
Measuring ~80 nm in diameter within a host lipid bilayer, the filovirion packages a 13.1–20.9 kb linear RNA genome lacking a 5' cap or 3' poly-A tail[4][16]. Cryo-electron tomography shows nucleoprotein (NP) encapsidating RNA into a left-handed helix stiffened by VP24 and VP35 proteins[17][19]. Because the viral RNA-dependent RNA polymerase initiates transcription at the 3' promoter and attenuates across intergenic junctions along 3'-NP–VP35–VP40–GP–VP30–VP24–L-5', structural NP is transcribed in vast excess over the 5'-distal L polymerase[4][5][20].
3. Molecular Life Cycle: NPC1 Entry, GP Editing, VP40 Plasticity, and VP24/VP30 Regulation
Trimeric surface glycoprotein (GP), shielded from antibodies by N- and O-linked glycosylation, binds C-type lectins, TIM-1, and TAM kinases to trigger macropinocytosis[16][21][23]. In acidic late endosomes, cathepsin B and L proteases remove the glycan cap, exposing GP1 to bind Niemann-Pick C1 (NPC1); GP2 then collapses into a six-helix bundle to fuse membranes and release the nucleocapsid into the cytoplasm[15][16][21].
Unlike Marburg virus, Orthoebolavirus and Cuevavirus mitigate GP cytotoxicity in the endoplasmic reticulum via co-transcriptional RNA editing: the viral RNA polymerase predominantly synthesizes unedited antibody-decoy sGP (~70–80%) but stutters at a hepta-uridine tract (~20–30%) to insert an extra adenosine into messenger RNA, frameshifting translation to full-length spike GP[18][21][28]. Matrix protein VP40 exhibits structural plasticity—folding as a trafficking butterfly dimer, a membrane-budding hexamer, or an RNA-binding octameric ring triggered by guanine/adenine-rich host mRNA[7][35][37]. Dynamic VP30 phosphorylation at Ser29 (by SRPK1 versus NP-scaffolded PP2A-B56α dephosphorylation) switches the polymerase from transcription to replication[29][40][42], while Ebola VP24 competitively binds karyopherin $α$5 (KPNA5) to block phosphorylated STAT1 nuclear import and silence interferon signaling[47][49].
4. Zoonotic Epidemiology, SEIR Dynamics, and Historical Outbreaks
Spilling over from Egyptian fruit bats (Rousettus aegyptiacus) or bushmeat intermediates, filoviruses transmit via infected bodily fluids, unsterilized needles, and post-mortem funeral contact[52][55]. In SEIR epidemiology rooted in Kermack-McKendrick theory, the Ebola basic reproduction number (R0) averages 1.3–2.0 (1.83 in 1995 Kikwit; 1.34 in 2000 Uganda), with nosocomial superspreading reaching 5–10[59][61][62].
| Year | Location | Virus Species | Cases | Deaths | CFR (%) | Source |
|---|---|---|---|---|---|---|
| 1967 | Germany/Yugoslavia | Marburg virus | 31 | 7 | 23% | [52][64] |
| 1976 | Zaire (DRC) | Ebola virus | 318 | 280 | 88% | [1][65] |
| 1995 | DRC | Ebola virus | 315 | 250 | 79% | [65][66] |
| 2000 | Uganda | Sudan virus | 425 | 224 | 53% | [65][66] |
| 2004-05 | Angola | Marburg virus | 252 | 227 | 90% | [65][67][68] |
| 2014-16 | West Africa (Multi) | Ebola virus | ~28,600 | ~11,323 | ~40-60% | [67][69] |
| 2023 | Equatorial Guinea | Marburg virus | 16 | 12* | 75% | [52][70] |
| 2024 | Rwanda | Marburg virus | 66 | 15 | 23% | [52][70] |
| 2026 | DRC / Uganda | Bundibugyo virus | >1,700 | >600 | ~31-35% | [3][71] |
Landmark outbreaks span the 1967 Marburg discovery from imported Ugandan monkeys (Cercopithecus aethiops)[64]; the 1976 Yambuku Zaire (88% CFR, isolated by Peter Piot's team) and Nzara Sudan epidemics[55][58][74]; the 2014–2016 West African epidemic (>28,600 cases, >11,300 deaths)[66]; and the 2026 Bundibugyo crisis in Mongbwalu, Ituri Province (>1,700 cases, >600 deaths across DRC and Uganda)[2][3][76][77].
5. Clinical Pathology, Vaccines, Monoclonal Cocktails, and EUL Diagnostics
After a 2–21 day incubation, fever and myalgia progress to gastrointestinal fluid loss, endothelial and hepatic injury, coagulopathy, multiorgan failure around days 8–9, or persistence in immune-privileged sites[32][52][57]. While single-dose rVSV-ZEBOV Ervebo (FDA-approved 2019; following May 2026 EU withdrawal of Zabdeno/Mvabea) and monoclonal therapies Inmazeb and Ebanga transformed Zaire ebolavirus care, they lack licensed efficacy against BDBV—spurring evaluation of cross-reactive maftivimab and the July 2, 2026 WHO Emergency Use Listing of the first rapid BDBV assay[79][80][81][82][84][87].
6. Conclusion: Conserved Targets for Pan-Filovirus Preparedness
Filoviruses achieve high lethality via GP RNA editing, VP40 conformational switching, VP30 phosphorylation toggles, and VP24-KPNA5 immune blockade. Containing the 2026 Bundibugyo crisis requires pan-filovirus vaccines, broad-spectrum therapeutics targeting conserved NPC1 and polymerase domains, and decentralized diagnostics.
Works Cited
- Ebola disease - BMJ Best Practice, https://bestpractice.bmj.com/topics/en-gb/1210/pdf/1210.pdf
- Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda, https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON612
- Ebola Outbreak: Current Situation - CDC, https://www.cdc.gov/ebola/situation-summary/index.html
- ICTV Virus Taxonomy Profile: Filoviridae 2024 - PMC - NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC11145875/
- (PDF) ICTV Virus Taxonomy Profile: Filoviridae 2024 - ResearchGate, https://www.researchgate.net/publication/377922771_ICTV_Virus_Taxonomy_Profile_Filoviridae_2024
- ICTV Virus Taxonomy Profile: Filoviridae 2024 - PubMed - NIH, https://pubmed.ncbi.nlm.nih.gov/38305775/
- Conformational plasticity of the Ebola virus matrix protein - PMC - NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC4241103/
- New Taxonomy Release: MSL41 - ICTV, https://ictv.global/news/MSL41
- Changes to Virus Taxonomy 2025 - ICTV, https://ictv.global/news/AoV-MSL40
- New Taxonomy Release: MSL40 - ICTV, https://ictv.global/news/taxonomy_2024
- Species List: Filoviridae - ICTV, https://ictv.global/report/chapter/filoviridae/taxonomy/filoviridae
- On the alleged danger of the Lloviu filovirus to human health - Secemu, https://secemu.org/en/on-the-alleged-danger-of-the-lloviu-filovirus-to-human-health/
- Isolation of infectious Lloviu virus from Schreiber's bats in Hungary - PMC - NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC8971391/
- Pathogenicity of Lloviu and Bombali Viruses in Type I Interferon Receptor Knockout Mice, https://pmc.ncbi.nlm.nih.gov/articles/PMC10651197/
- Structural and Functional Aspects of Ebola Virus Proteins - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC8538763/
- Ebola Virus Entry into Host Cells: Identifying Therapeutic Strategies - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4617201/
- Structural basis of Ebola virus nucleocapsid assembly and functions - bioRxiv, https://www.biorxiv.org/content/10.1101/2024.02.19.580633v1.full-text
- Genus: Cuevavirus | ICTV, https://ictv.global/report/chapter/filoviridae/filoviridae/cuevavirus
- Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography | PNAS, https://www.pnas.org/doi/10.1073/pnas.1120453109
- Deep Sequencing Identifies Noncanonical Editing of Ebola and Marburg Virus RNAs in Infected Cells - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4222107/
- Ebola Virus Glycoprotein: Structure, Entry Mechanism, and Therapeutic Implications, https://www.creative-biolabs.com/vaccine/ebola-virus-glycoprotein-structure-entry-mechanism-and-therapeutic-implications.htm
- Analysis of Ebola Virus Entry Into Macrophages | The Journal of Infectious Diseases, https://academic.oup.com/jid/article/212/suppl_2/S247/2193955
- Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis, https://pmc.ncbi.nlm.nih.gov/articles/PMC3189988/
- Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC2944813/
- Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion - Research journals - PLOS, https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0001395
- Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4474285/
- GP - Envelope glycoprotein - Zaire ebolavirus (strain Gabon-94) (ZEBOV) | UniProtKB, https://www.uniprot.org/uniprotkb/O11457/entry
- RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor, https://academic.oup.com/jid/article/212/suppl_2/S226/2194345
- Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC9601197/
- Genomic RNA Editing and Its Impact on Ebola Virus Adaptation During Serial Passages in Cell Culture and Infection of Guinea Pigs | The Journal of Infectious Diseases | Oxford Academic, https://academic.oup.com/jid/article/204/suppl_3/S941/2192499
- A New Ebola Virus Nonstructural Glycoprotein Expressed through RNA Editing - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC3094950/
- The Multiple Roles of sGP in Ebola Pathogenesis - PMC - NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC4287119/
- RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor - PubMed, https://pubmed.ncbi.nlm.nih.gov/26138826/
- Conformational plasticity of the Ebola virus matrix protein - PubMed, https://pubmed.ncbi.nlm.nih.gov/25159197/
- Conformational Flexibility of the Protein–Protein Interfaces of the Ebola Virus VP40 Structural Matrix Filament | The Journal of Physical Chemistry B - ACS Publications, https://pubs.acs.org/doi/10.1021/acs.jpcb.9b04674
- 4LDD: Crystal Structure of Ebola virus VP40 Hexamer - RCSB PDB, https://www.rcsb.org/structure/4ldd
- Molecule of the Month: Ebola Virus Proteins - PDB-101, https://pdb101.rcsb.org/motm/178
- The Matrix Protein VP40 from Ebola Virus Octamerizes into Pore-like Structures with Specific RNA Binding Properties - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC7126486/
- Shape-shifting Ebola virus protein exploits human RNA to change shape – lji.org, https://www.lji.org/news-events/news/post/shape-shifting-ebola-virus-protein-exploits-human-rna-to-change-shape/
- Phosphorylation of Ebola Virus VP30 Influences the Composition of the Viral Nucleocapsid Complex - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC3630872/
- Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle - ASM Journals, https://journals.asm.org/doi/10.1128/jvi.03257-15
- Full article: To be or not to be phosphorylated: understanding the role of Ebola virus nucleoprotein in the dynamic interplay with the transcriptional activator VP30 and the host phosphatase PP2A-B56 - Taylor & Francis, https://www.tandfonline.com/doi/full/10.1080/22221751.2024.2447612
- Role of Ebola Virus VP30 in Transcription Reinitiation - ASM Journals, https://journals.asm.org/doi/10.1128/jvi.01395-08
- Role of VP30 phosphorylation in the Ebola virus replication cycle - PubMed, https://pubmed.ncbi.nlm.nih.gov/21987772/
- Role of VP30 Phosphorylation in the Ebola Virus Replication Cycle - Oxford Academic, https://academic.oup.com/jid/article-abstract/204/suppl_3/S934/2192470
- Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene | mBio, https://journals.asm.org/doi/abs/10.1128/mbio.02243-22
- The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import - PubMed, https://pubmed.ncbi.nlm.nih.gov/21987768/
- Ebola Virus VP24 Protein Prevents hnRNP C1/C2 Binding to Karyopherin α1 and Partially Alters its Nuclear Import | The Journal of Infectious Diseases | Oxford Academic, https://academic.oup.com/jid/article/204/suppl_3/S904/2192534
- Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1 - PubMed, https://pubmed.ncbi.nlm.nih.gov/25121748/
- Ebola virus VP24 targets a unique NLS-binding site on karyopherin5 to selectively compete with nuclear import of phosphorylated STAT1 - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4188415/
- The Biophysical Basis for Karyopherin-Dependent Ebola Virus VP24 Nuclear Transport, https://www.mdpi.com/1999-4915/17/8/1051
- Marburg virus disease - World Health Organization (WHO), https://www.who.int/news-room/fact-sheets/detail/marburg-virus-disease
- Marburg virus disease - World Health Organization (WHO), https://www.who.int/health-topics/marburg-virus-disease
- Ebolavirus and Marburgvirus Infections - The Center for Food Security and Public Health, https://www.cfsph.iastate.edu/Factsheets/pdfs/viral_hemorrhagic_fever_filovirus.pdf
- Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013–2016, https://academic.oup.com/jid/article-pdf/214/suppl_3/S93/7935916/jiw207.pdf
- Notes from the Field: Outbreak of Ebola Disease Caused by Bundibugyo Virus — Democratic Republic of the Congo and Uganda, May 2026 | MMWR - CDC, https://www.cdc.gov/mmwr/volumes/75/wr/mm7522e3.htm
- Filoviruses (Infection with) | WOAH, https://www.woah.org/app/uploads/2022/02/filoviruses-infection-with.pdf
- 1976 Zaire Ebola virus outbreak - Wikipedia, https://en.wikipedia.org/wiki/1976_Zaire_Ebola_virus_outbreak
- Rapid drop in the reproduction number during the Ebola outbreak in the Democratic Republic of Congo - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4655090/
- Understanding the Basic Reproduction Number (R0): The Key to Tracking Disease Spread, https://www.gideononline.com/blogs/understanding-the-basic-reproduction-number-r0-the-key-to-tracking-disease-spread/
- (PDF) The Basic Reproductive Number of Ebola and the Effects of Public Health Measures: The Cases of Congo and Uganda - ResearchGate, https://www.researchgate.net/publication/8529056_The_Basic_Reproductive_Number_of_Ebola_and_the_Effects_of_Public_Health_Measures_The_Cases_of_Congo_and_Uganda
- The basic reproduction number (R0) of ebola virus disease: A systematic review and meta-analysis - PubMed, https://pubmed.ncbi.nlm.nih.gov/38181864/
- Basic reproduction number - Wikipedia, https://en.wikipedia.org/wiki/Basic_reproduction_number
- 1967 Marburg virus disease outbreak - Wikipedia, https://en.wikipedia.org/wiki/1967_Marburg_virus_disease_outbreak
- EBOLA-MARBURG VIRAL DISEASES - American Public Health Association, https://www.apha.org/getcontentasset/82f1161e-a2af-4f3c-81c2-630ed4ed7677/7ca0dc9d-611d-46e2-9fd3-26a4c03ddcbb/ccdm_ebola.pdf?language=en
- Chapter 2: Major Ebola outbreaks in Africa | Mercy Corps, https://www.mercycorps.org/blog/ebola-outbreaks-africa-guide/chapter-2
- History of Ebola Outbreaks - CDC, https://www.cdc.gov/ebola/outbreaks/index.html
- Ebola disease outbreak in the Democratic Republic of the Congo and Uganda - ECDC, https://www.ecdc.europa.eu/en/ebola-outbreak-democratic-republic-congo-and-uganda
- Etymologia: Marburg Virus - PMC - NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC5621541/
- The First Ebola Epidemic - Biomol GmbH, https://resources.biomol.com/biomol-blog/the-first-ebola-epidemic
- Uncovering the Ebolavirus: The Journey of ITM Researchers in Discovery and Research | Institute of Tropical Medicine, https://www.itg.be/en/health-stories/impact-stories/the-discovery-of-and-research-on-the-ebola-virus
- Interview with Peter Piot Discoverer of the Ebola Virus - DER SPIEGEL, https://www.spiegel.de/international/world/interview-with-peter-piot-discoverer-of-the-ebola-virus-a-993111.html
- DR Congo/Uganda: Ebola Outbreak - May 2026 | ReliefWeb, https://reliefweb.int/disaster/ep-2026-000071-cod
- Visualised: how conflict, aid cuts and health-worker attacks are helping Ebola spread in DRC, https://www.theguardian.com/world/2026/jul/10/visualised-how-conflict-aid-cuts-and-health-worker-attacks-are-helping-ebola-spread-in-drc
- Ebola Crisis Explained, https://www.unrefugees.org/news/2026/7/ebola-crisis-explained/
- Ebola Vaccine Product Information - CDC, https://www.cdc.gov/ebola/hcp/vaccines/index.html
- Ebola - FDA, https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/ebola
- Ebola (Bundibugyo) Day 15: The Status of Diagnostics, Investigational Therapeutics and Vaccines – IPPS, https://ippsecretariat.org/news/day-15-ebola-bdbv-2026/
- Zabdeno | European Medicines Agency (EMA), https://www.ema.europa.eu/en/medicines/human/EPAR/zabdeno
- Ebola vaccine - Wikipedia, https://en.wikipedia.org/wiki/Ebola_vaccine
- Regeneron's Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak, https://investor.regeneron.com/news-releases/news-release-details/regenerons-ebola-antibody-recommended-world-health-organization
- Orthoebolavirus zairense Treatment | Inmazeb® (atoltivimab, maftivimab, and odesivimab-ebgn), https://www.inmazeb.com/
- Ebola outbreak - DRC 2026 - World Health Organization (WHO), https://www.who.int/emergencies/situations/ebola-outbreak---drc-2026
- WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing, https://www.who.int/news/item/02-07-2026-who-adds-first-diagnostic-test-for-ebola-bundibugyo-virus-to-its-emergency-use-listing
- WHO Adds First Diagnostic Test for Ebola Bundibugyo Virus to Emergency Use Listing, https://clpmag.com/disease-states/infectious-diseases/emerging-zoonotic-diseases/who-emergency-listing-bundibugyo-ebola-diagnostic-test/
- WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing, https://epinews.emphnet.net/en/news/eastern-mediterranean/who-adds-first-diagnostic-test-for-ebola-bundibugyo-virus-to-its-emergency-use-listing
- WHO Adds First Bundibugyo Ebola Molecular Test to Emergency Use Listing - LabMedica, https://www.labmedica.com/molecular-diagnostics/articles/294811818/who-adds-first-bundibugyo-ebola-molecular-test-to-emergency-use-listing.html